发明名称 |
INTRANASAL ADMINISTRATION OF PHYSOSTIGMINE AND ARECOLINE |
摘要 |
TITLE INTRANASAL ADMINISTRATION OF PHYSOSTIGMINE AND ARECOLINE The intranasal administration of arecoline and physostigmine is provided for the treatment of a cognitive deficiency. Such administration of physostigmine is also used to treat overdoses of anticholinergic drugs or to protect a mammal against organophosphate poisoning. Intranasal delivery of these drugs offers a convenient dosage form with efficient bioavailability.
|
申请公布号 |
CA2012192(A1) |
申请公布日期 |
1990.09.28 |
申请号 |
CA19902012192 |
申请日期 |
1990.03.14 |
申请人 |
DU PONT (E. I.) DE NEMOURS AND COMPANY |
发明人 |
HUSSAIN, MUNIR A.;MOLLICA, JOSEPH A. |
分类号 |
A61K9/08;A61K9/00;A61K9/107;A61K31/40;A61K31/44;A61P25/28;A61P39/02;(IPC1-7):A61K31/455 |
主分类号 |
A61K9/08 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|